Skip Nav Destination
Issues
15 September 2015
-
Cover Image
Cover Image
The cover shows a section of a benign peripheral nerve sheath tumor (plexiform neurofibroma) from a patient with neurofibromatosis type 1 (NF1). Hematoxylin and eosin staining reveals the abundant collagen deposition in this tumor. For details, see the article by Hirbe and colleagues on page 4201 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
20th Anniversary Commentary
CCR Translations
CCR Perspectives in Drug Approval
FDA Approval: Blinatumomab
Donna Przepiorka; Chia-Wen Ko; Albert Deisseroth; Carolyn L. Yancey; Reyes Candau-Chacon; Haw-Jyh Chiu; Brenda J. Gehrke; Candace Gomez-Broughton; Robert C. Kane; Susan Kirshner; Nitin Mehrotra; Tiffany K. Ricks; Deborah Schmiel; Pengfei Song; Ping Zhao; Qing Zhou; Ann T. Farrell; Richard Pazdur
Molecular Pathways
Cancer Therapy: Clinical
Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805
Naomi B. Haas; Judith Manola; Bonnie Ky; Keith T. Flaherty; Robert G. Uzzo; Christopher J. Kane; Michael Jewett; Lori Wood; Christopher G. Wood; Michael B. Atkins; Janice J. Dutcher; George Wilding; Robert S. DiPaola
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown; Behnam Badie; Michael E. Barish; Lihong Weng; Julie R. Ostberg; Wen-Chung Chang; Araceli Naranjo; Renate Starr; Jamie Wagner; Christine Wright; Yubo Zhai; James R. Bading; Julie A. Ressler; Jana Portnow; Massimo D'Apuzzo; Stephen J. Forman; Michael C. Jensen
Personalized Medicine and Imaging
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
Hui-Ming Chen; Ge Ma; Neil Gildener-Leapman; Samuel Eisenstein; Brian A. Coakley; Junko Ozao; John Mandeli; Celia Divino; Myron Schwartz; Max Sung; Robert Ferris; Johnny Kao; Lu-Hai Wang; Ping-Ying Pan; Eric C. Ko; Shu-Hsia Chen
Cancer Therapy: Preclinical
Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma
Kelly M. Zullo; Yige Guo; Laurence Cooke; Xavier Jirau-Serrano; Michael Mangone; Luigi Scotto; Jennifer E. Amengual; Yinghui Mao; Renu Nandakumar; Serge Cremers; Jimmy Duong; Daruka Mahadevan; Owen A. O'Connor
Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
Helle J. Jacobsen; Thomas T. Poulsen; Anna Dahlman; Ida Kjær; Klaus Koefoed; Jette W. Sen; Dietmar Weilguny; Bolette Bjerregaard; Christina R. Andersen; Ivan D. Horak; Mikkel W. Pedersen; Michael Kragh; Johan Lantto
Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models
Teresa Troiani; Stefania Napolitano; Giulia Martini; Erika Martinelli; Claudia Cardone; Nicola Normanno; Donata Vitagliano; Floriana Morgillo; Francesca Fenizia; Matilde Lambiase; Luigi Formisano; Roberto Bianco; Davide Ciardiello; Fortunato Ciardiello
Author Choice
Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions
Marc Damelin; Alexander Bankovich; Albert Park; Jorge Aguilar; Wade Anderson; Marianne Santaguida; Monette Aujay; Sarah Fong; Kiran Khandke; Virginia Pulito; Elana Ernstoff; Paul Escarpe; Jeffrey Bernstein; Marybeth Pysz; Wenyan Zhong; Erik Upeslacis; Judy Lucas; Justin Lucas; Timothy Nichols; Kathryn Loving; Orit Foord; Johannes Hampl; Robert Stull; Frank Barletta; Hadi Falahatpisheh; Puja Sapra; Hans-Peter Gerber; Scott J. Dylla
Biology of Human Tumors
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing
Marina Parry; Matthew J.J. Rose-Zerilli; Viktor Ljungström; Jane Gibson; Jun Wang; Renata Walewska; Helen Parker; Anton Parker; Zadie Davis; Anne Gardiner; Neil McIver-Brown; Christina Kalpadakis; Aliki Xochelli; Achilles Anagnostopoulos; Claudia Fazi; David Gonzalez de Castro; Claire Dearden; Guy Pratt; Richard Rosenquist; Margaret Ashton-Key; Francesco Forconi; Andrew Collins; Paolo Ghia; Estella Matutes; Gerassimos Pangalis; Kostas Stamatopoulos; David Oscier; Jonathan C. Strefford
Author Choice
Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival
Sébastien Salas; Celine Brulard; Philippe Terrier; Dominique Ranchere-Vince; Agnes Neuville; Louis Guillou; Marick Lae; Agnes Leroux; Olivier Verola; Kurtz Jean-Emmanuel; Sylvie Bonvalot; Jean-Yves Blay; Axel Le Cesne; Alain Aurias; Jean-Michel Coindre; Frederic Chibon
Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma
Angela C. Hirbe; Sonika Dahiya; Christopher A. Miller; Tiandao Li; Robert S. Fulton; Xiaochun Zhang; Sandra McDonald; Katherine DeSchryver; Eric J. Duncavage; Jessica Walrath; Karlyne M. Reilly; Haley J. Abel; Melike Pekmezci; Arie Perry; Timothy J. Ley; David H. Gutmann
Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer
Grant D. Stewart; Fiach C. O'Mahony; Alexander Laird; Lel Eory; Alexander L.R. Lubbock; Alan Mackay; Jyoti Nanda; Marie O'Donnell; Peter Mullen; S. Alan McNeill; Antony C.P. Riddick; Daniel Berney; Axel Bex; Michael Aitchison; Ian M. Overton; David J. Harrison; Thomas Powles
Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
Michael P. Gustafson; Yi Lin; Jonathan S. Bleeker; Deepti Warad; Matthew K. Tollefson; Paul L. Crispen; Peggy A. Bulur; Susan M. Harrington; Rebecca R. Laborde; Dennis A. Gastineau; Bradley C. Leibovich; John C. Cheville; Eugene D. Kwon; Allan B. Dietz
Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
Atsushi Yamada; Takahiro Horimatsu; Yoshinaga Okugawa; Naoshi Nishida; Hajime Honjo; Hiroshi Ida; Tadayuki Kou; Toshihiro Kusaka; Yu Sasaki; Makato Yagi; Takuma Higurashi; Norio Yukawa; Yusuke Amanuma; Osamu Kikuchi; Manabu Muto; Yoshiyuki Ueno; Atsushi Nakajima; Tsutomu Chiba; C. Richard Boland; Ajay Goel
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.